Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Brunei.
Press releases published on August 29, 2025
Pandag Tech's G1 Robotic Mower Draws Strong Interest at Major Australian Agricultural Events
GlobeNewswire
·
August 29, 2025
GUNNEDAH, Australia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pandag Tech marked a successful Australian market debut at AgQuip and Dowerin Field Day this month, with its flagship Pandag G1 robotic mower drawing lots of professional visitors and generating …
Panasonic TOUGBOOK Showcases Mission-Ready Defence Solutions at DSEI 2025
GlobeNewswire
·
August 29, 2025
Panasonic TOUGHBOOK to deliver immersive demonstrations of rugged, mission-ready technology aligned with the UK’s Strategic Defence Review (SDR) 2025, supporting national security and NATO interoperability at DSEI London. Bracknell, UK. 29th August 2025 – …
Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms …
RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global RNA Polymerase I Clinical Trials, Development Trends By Indications, Target Approaches …
Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches …
Bispecific Antibody Drug Conjugates ADC Clinical Trials FDA Approval Companies Commercial Launch Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape and Market Opportunity Insight 2025 Report Findings and Highlights: First Bispecific Antibody Drug Conjugate …
Controlled Release Drug Delivery Market Size FDA Approved Drugs Clinical Trials Companies Report 2030
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Controlled Release Drug Delivery Market, Drug Dosage, Price, Sales and Clinical Trials Insight 2030 Report Finding and Highlights: Research Methodology Followed Global and Regional Market Overview Global …
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
GlobeNewswire
·
August 29, 2025
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today published a comprehensive …
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale
GlobeNewswire
·
August 29, 2025
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale NANTES, France - 29 août 2025, 8h00 CET – OSE Immunotherapeutics SA (ISIN: …
Santhera schliesst Vereinbarung mit Ikris Pharma Network über den Vertrieb von AGAMREE® (Vamorolon) in Indien
GlobeNewswire
·
August 29, 2025
Pratteln, Schweiz, 29. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Ikris Pharma Network (Ikris) über den Vertrieb von AGAMREE® (Vamorolon) in Indien zur Behandlung von Duchenne- …
Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India
GlobeNewswire
·
August 29, 2025
Pratteln, Switzerland, 29 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in India, for the treatment of Duchenne …
American Rebel Holdings Clarifies: No Amended S-1 Filed on August 28; Webull/Benzinga Posts Mischaracterized Prior June 3 Filing
GlobeNewswire
·
August 29, 2025
After fielding multiple investor calls prompted by misleading August 28 Benzinga posts, the Company confirms no new S-1/A was filed; the referenced amendment was filed June 3, 2025, and the referenced registration was declared effective June 27, 2025. …
Snail Games 凭借新里程碑、行业活动及即将发布的作品推进多品牌发行战略
GlobeNewswire
·
August 29, 2025
卡尔弗城，加利福尼亚州, Aug. 29, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的互动数字娱乐独立开发商和发行商，Snail, Inc.（Nasdaq：SNAL，以下称为“Snail Games”或“公司”）今日重点展示了其旗下各发行品牌所取得的一系列里程碑成果。 这些进展凸显了公司在多平台、多类型游戏及各类行业活动中灵活运作的能力，进一步彰显了 Snail 持续推进的广泛市场参与和增长战略。 Snail Games 与 Studio Sirens 联手在 Epic …
Snail Games 推進多品牌發行策略，公佈新里程碑、展會活動及即將上市新作
GlobeNewswire
·
August 29, 2025
卡爾弗城，加州, Aug. 29, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商和發行商 Snail, Inc. (Nasdaq: SNAL) (「Snail Games」或「公司」)，今天重點介紹了其發行品牌組合的一系列里程碑。 這些發展彰顯公司展開跨越多平台、遊戲類型及行業活動的能力，強化 Snail 廣泛市場參與和增長的持續策略。 Snail Games 與 Studio Sirens 在 Epic Games Store 發佈了更新版 ARK DevKit，在《 …
STACK Infrastructure Reinforces Responsible Development Principles through Project Jupiter in New Mexico
GlobeNewswire
·
August 29, 2025
DENVER, Aug. 28, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, announced today its role in Project Jupiter, …
Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil®
GlobeNewswire
·
August 29, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended June 30, 2025. …